SALA, GESSICA
 Distribuzione geografica
Continente #
NA - Nord America 9.304
EU - Europa 5.059
AS - Asia 4.470
SA - Sud America 719
AF - Africa 84
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 5
Totale 19.651
Nazione #
US - Stati Uniti d'America 9.077
SG - Singapore 1.718
IT - Italia 1.165
CN - Cina 1.163
DE - Germania 802
RU - Federazione Russa 705
SE - Svezia 612
BR - Brasile 582
HK - Hong Kong 539
VN - Vietnam 456
IE - Irlanda 398
UA - Ucraina 314
GB - Regno Unito 303
FI - Finlandia 160
IN - India 153
CA - Canada 150
AT - Austria 146
FR - Francia 110
PL - Polonia 86
KR - Corea 72
NL - Olanda 66
MX - Messico 55
AR - Argentina 54
ID - Indonesia 54
JP - Giappone 54
TR - Turchia 51
DK - Danimarca 48
BE - Belgio 42
BD - Bangladesh 39
IR - Iran 39
ES - Italia 35
IQ - Iraq 31
ZA - Sudafrica 29
EC - Ecuador 23
PK - Pakistan 16
EG - Egitto 15
VE - Venezuela 15
LT - Lituania 13
SA - Arabia Saudita 13
CO - Colombia 12
KE - Kenya 11
CZ - Repubblica Ceca 10
CH - Svizzera 9
EU - Europa 9
UZ - Uzbekistan 9
IL - Israele 8
MA - Marocco 8
PE - Perù 8
PT - Portogallo 8
PY - Paraguay 8
AE - Emirati Arabi Uniti 7
CL - Cile 7
TW - Taiwan 7
JM - Giamaica 6
MY - Malesia 6
DZ - Algeria 5
GR - Grecia 5
JO - Giordania 5
PH - Filippine 5
RO - Romania 5
UY - Uruguay 5
BO - Bolivia 4
ET - Etiopia 4
CI - Costa d'Avorio 3
HU - Ungheria 3
KZ - Kazakistan 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
OM - Oman 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AU - Australia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CR - Costa Rica 2
CY - Cipro 2
EE - Estonia 2
GA - Gabon 2
GT - Guatemala 2
HN - Honduras 2
KG - Kirghizistan 2
MU - Mauritius 2
NP - Nepal 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
A1 - Anonimo 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GE - Georgia 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
Totale 19.643
Città #
Ann Arbor 1.609
Singapore 1.027
Ashburn 886
Woodbridge 679
Chandler 545
Hong Kong 532
Frankfurt am Main 504
Houston 498
Fairfield 392
Dublin 382
Milan 381
Jacksonville 345
Wilmington 321
New York 272
Dearborn 263
Santa Clara 249
Dallas 246
Beijing 179
Seattle 172
Los Angeles 157
Princeton 152
Ho Chi Minh City 149
San Jose 142
Cambridge 137
Vienna 129
Shanghai 111
Hefei 106
Nanjing 94
Hanoi 92
The Dalles 74
Boardman 70
São Paulo 62
Lachine 61
Buffalo 59
Helsinki 57
Moscow 57
Munich 54
Altamura 53
Seoul 53
Guangzhou 50
Lawrence 47
Jakarta 46
Kraków 44
Chicago 42
Brussels 41
Rome 39
Fremont 36
London 35
Shenyang 33
Tokyo 33
Changsha 32
Pisa 32
Council Bluffs 28
Nanchang 28
San Diego 28
Turku 28
Tianjin 27
Warsaw 27
Dong Ket 26
Jinan 25
Andover 24
Turin 24
Toronto 23
Zhengzhou 23
Denver 22
Falls Church 22
Hebei 22
Grafing 21
Monza 21
Orem 21
Ottawa 21
Pune 21
Rio de Janeiro 21
Poplar 20
Jiaxing 19
Lecco 19
Phoenix 19
Chennai 18
Johannesburg 18
Montreal 18
San Francisco 18
Stockholm 18
Atlanta 17
Belo Horizonte 16
Brooklyn 16
Ningbo 16
Tehran 16
Biên Hòa 15
Da Nang 15
Mexico City 15
Amsterdam 13
Haiphong 13
Manchester 13
Nuremberg 13
Boston 12
Buenos Aires 12
Lappeenranta 12
Mountain View 12
Columbus 11
Hangzhou 11
Totale 12.779
Nome #
ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability 578
NMR-driven identification of anti-amyloidogenic compounds in green and roasted coffee extracts 468
Rotenone down-regulates HSPA8/hsc70 chaperone protein in vitro: A new possible toxic mechanism contributing to Parkinson's disease 422
Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis 383
Oxidative stress and altered mitochondrial dynamics in neurodegenerative processes 375
Ischemic Conditions Affect Rerouting of Tau Protein Levels: Evidences for Alteration in Tau Processing and Secretion in Hippocampal Neurons 356
NMR-based Lavado cocoa chemical characterization and comparison with fermented cocoa varieties: Insights on cocoa's anti-amyloidogenic activity 345
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 327
Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8) 326
Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients 307
HSC70 expression is reduced in lymphomonocytes of sporadic ALS patients and contributes to TDP-43 accumulation 307
Rotenone upregulates alpha-synuclein and myocyte enhancer factor 2D independently from lysosomal degradation inhibition 298
Peripheral cytokine release in Alzheimer patients: Correlation with disease severity 295
Reduced platelet glutamate uptake in Parkinson's disease 295
In vitro study of autophagy dysfunctions associated with Parkinson’s disease 283
Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease 279
Rotenone-induced down-regulation of HSPA8/hsc70 protein increases alphasynuclein in vitro: possible implications for Parkinson’s disease 278
Study of alpha-synuclein and its catabolic pathways in ex vivo cells of patients with Parkinson’s disease 274
NMR-driven identification of cinnamon bud and bark components with anti-Aβ activity 273
Rotenone down-regulates hspa8/hsc70 protein in vitro: a new possible toxic mechanism contributing to Parkinson’s disease 268
Riluzole display glutamate-independent antioxidant properties: relevance for ALS 267
Digested Cinnamon (Cinnamomum verum J. Presl) Bark Extract Modulates Claudin-2 Gene Expression and Protein Levels under TNFα/IL-1β Inflammatory Stimulus 262
MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients 256
Reduced expression of the chaperone-mediated autophagy carrier hsc70 protein in lymphomonocytes of patients with Parkinson's disease 256
Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines 254
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 253
Study Of Chaperone Mediated Autophagy in Lymphomonocytes of sporadic and familial als patients evidenced Hsc70 reduction and TDP-43 aggregation 253
Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis 252
Effect of mitochondrial complex I inhibition on chaperone-mediated and myocyte enhancer factor 2D in human neuroblastoma cells 252
Valproate and HDAC inhibition: A new epigenetic strategy to mitigate phenotypic severity in ALS? 251
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 245
Reduced expression of hsc70 protein in lymphomonocytes of patients with Parkinson's disease 244
Alpha-Synuclein, Oxidative Stress and Autophagy Failure: Dangerous Liaisons in Dopaminergic Neurodegeneration 243
Decreased platelet glutamate uptake and genetic risk factors in patients with Parkinson's disease 240
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores 240
New insights into the genetic etiology of Alzheimer's disease and related dementias 240
Alzheimer's Disease Prevention through Natural Compounds: Cell-Free, In Vitro, and In Vivo Dissection of Hop (Humulus lupulus L.) Multitarget Activity 238
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis 237
Nerve growth factor and transforming growth factor-β serum levels in acute stroke patients: Possible involvement of neurotrophins in cerebrovascular disease 236
Study of alpha-synuclein and its catabolic pathways in lymphomonocytes of patients with Parkinson's disease 236
Platelet glutamate uptake as peripheral marker of excitotoxicity in neurodegenerative disorders 234
Ischemic injury elicits the unconventional secretion of protein hallmarks of Alzheimer's disease onset as seeds for interneuronal propagation 233
Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemia 230
Vesicular monoamine transporter 2 mRNA levels are reduced in platelets from patients with Parkinson's disease 229
Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine 228
A panel of macroautophagy markers in lymphomonocytes of patients with amyotrophic lateral sclerosis 228
Role of chaperone-mediated autophagy dysfunctions in the pathogenesis of Parkinson’s disease 226
Lack of evidence for oxidative stress in sporadic amyotrophic lateral sclerosis fibroblasts 225
A Preliminary Study of Chaperone-Mediated Autophagy in ALS Lymphomonocytes 224
Mef2d-mef2c pathways are altered in lymphomonocytes of patients with sporadic and familial form of amyotrophic lateral sclerosis 222
Assessment of chaperone-mediated autophagy in circulating lymphomonocytes of patients with Parkinson disease 221
AUTOPHAGY ALTERATION UNDER ISCHEMIC CONDITION: A POSSIBLE LINK TO ALZHEIMER'S DISEASE 221
Exploring the role of autophagy in the pathogenesis of rotenone-induced toxicity 219
Huntington's disease and HDACi: Would sulpiride and valproate be of therapeutic value? 217
MEF2C and MEF2D alterations in sporadic and familial ALS patients: a possible correlation with disease progression? 217
MEF2D and MEF2C Pathways Disruption in Sporadic and Familial ALS Patients 217
Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro 216
the MonzALS collaborative network 212
HSPA8 knock-down induces the accumulation of neurodegenerative disorder-associated proteins 203
Inhibition of retrograde transport modulates misfolded protein accumulation and clearance in motoneuron diseases 202
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis 201
Myocyte enhancer factor-2D expression in ALS lymphomonocytes 197
Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis 193
Partial mitochondrial complex I inhibition induces oxidative damage and perturbs glutamate transport in primary retinal cultures. Relevance to Leber Hereditary Optic Neuropathy (LHON) 184
Macroautophagy is not altered in ALS lymphomonocytes 184
Analysis of glutamate transporters in peripheral cells: A tool to invistigate excitotoxicity in neurodegenerative disorders 183
Chaperone mediated autophagy in Parkinson's disease: Study in peripheral blood cells from patients and in a cellular model 182
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 178
Core blood biomarkers of Alzheimer's disease: A single-center real-world performance study 175
Dysfunction of chaperone-mediated autophagy in lymphomonocytes from patients with Parkinson's disease and in a cellular model 174
Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation 167
Antioxidants partially restore glutamate transport defect in leber hereditary optic neuropathy cybrids 159
Interactions between excitotoxicity and oxidative stress in ALS: clues for pharmacotherapy 158
Increased interleukin-6 release from peripheral blood cells of patients after brain trauma 156
Assessing glutamatergic function and dysfunction in peripheral tissues 155
Myocyte Enhacer Factor-2 Pathway Is Altered In Amyotrophic Lateral Sclerosis Peripheral Blood Mononuclear Cells 151
Whole-blood global DNA methylation and phenotypic variability in ALS 149
Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion 147
Recent advances in the therapy of amyotrophic lateral sclerosis: Focus on excitotoxicity 145
Author Correction: Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro (Scientific Reports, (2021), 11, 1, (2197), 10.1038/s41598-021-81693-8) 136
Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset 134
ALS genocopy due to co-existence of spastin mutation and SMN2 deletion? A 12 months open label trial with valproic acid 130
Neuroprotection and Non-Invasive Brain Stimulation: Facts or Fiction? 117
Platelets 114
Multicenter Translational Trial of Remote Ischemic Conditioning in Acute Ischemic Stroke (TRICS BASIC) 48
Iatrogenic Cerebral Amyloid Angiopathy-Related Inflammation: A Multicenter Case Series 32
Multicomponent interventions and technologies to reduce the burden of frailty, functional, and cognitive decline: insights from the Age-It Research Program 30
Totale 20.095
Categoria #
all - tutte 63.361
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.361


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021811 0 0 0 0 0 0 134 131 132 173 98 143
2021/20221.120 97 126 109 100 81 113 45 57 50 69 108 165
2022/20232.119 190 615 193 239 163 321 26 117 144 17 50 44
2023/20241.674 81 79 104 88 201 456 239 90 79 14 31 212
2024/20253.377 170 407 276 135 253 185 161 139 318 549 278 506
2025/20265.105 1.107 571 689 934 1.000 463 341 0 0 0 0 0
Totale 20.095